Group 1 - The core business of the company is the research, production, and sales of soybean protein series products [1] - The main product, soybean protein, is used in the production of health supplement protein powder [1] - The company has a stake in Shandong Meijike Biotechnology Co., Ltd., which focuses on the research, production, and sales of health food [1]

Group 1 - The core point of the article is that as of December 10, 2025, the number of shareholders for the company Suobao Protein is projected to be 16,079 [2]

Core Viewpoint - The company, Suobao Protein, announced a share reduction by its shareholders, Jinan Fosun and its concerted action party, Ningbo Fosun, which indicates a strategic shift in their investment position [1] Group 1: Shareholder Actions - Jinan Fosun and Ningbo Fosun collectively reduced their holdings by 298,000 shares [1] - The shareholding percentage decreased from 14.08% to 13.92%, crossing a 1% threshold [1]

Group 1 - The core point of the announcement is that Jinan Caijin Fuxing Weishi Equity Investment Fund Partnership and its action-in-concert party, Shanghai Fuxing Chuangfu Investment Management Co., Ltd., have reduced their shareholding in Ningbo Suobao Protein Technology Co., Ltd. by 298,000 shares, decreasing their total shareholding from 26,946,092 shares to 26,648,092 shares, which is a reduction from 14.08% to 13.92% of the total share capital [1][2] - The share reduction occurred between December 4 and December 5, 2025, and it triggered a change that crossed the 1% threshold [1] - The announcement confirms that this change in shareholding will not lead to a change in the controlling shareholder or actual controller of the company [2] Group 2 - The equity change does not require the disclosure of an equity change report and complies with relevant laws and regulations, including the Securities Law of the People's Republic of China [2] - The equity change aligns with the previously disclosed reduction plan and does not trigger a mandatory tender offer or involve any changes in funding sources [2] - The company will continue to monitor the progress of the reduction plan and fulfill its information disclosure obligations as required [2]

1.身份类别 | | □控股股东/实际控制人及其一致行动人 ☑其他 | | --- | --- | | | 5%以上大股东及其一致行动人 | | 投资者及其一致行动人的身份 | □合并口径第一大股东及其一致行动人（仅适用 | | | 于无控股股东、实际控制人） | | | □其他______________（请注明） | 重要内容提示： 权益变动方向 比例增加□ 比例减少☑ 权益变动前合计比例 14.08% 权益变动后合计比例 13.92% 本次变动是否违反已作出的承 诺、意向、计划 是□ 否☑ 是否触发强制要约收购义务 是□ 否☑ 二、 权益变动触及 1%刻度的基本情况 宁波索宝蛋白科技股份有限公司（以下简称"公司"）于 2025 年 12 月 8 日收到股东济南财金复星惟实股权投资基金合伙企业（有限合伙）（以下简称"济 南复星"）及其一致行动人上海复星创富投资管理股份有限公司－宁波梅山保税 港区复星惟盈股权投资基金合伙企业（有限合伙）（以下简称"宁波复星"）出具 的《关于减持宁波索宝蛋白科技股份有限公司股份跨越 1%整数倍的告知函》。于 2025 年 12 月 4 日-12 月 5 日期间，济南复星、宁波 ...

Core Viewpoint - The company, Suobao Protein (603231.SH), announced a significant share reduction by its shareholders, which may impact the stock's market perception and investor confidence [1] Group 1: Shareholder Actions - The shareholders, Jinan Caijin Fuxing Weishi Equity Investment Fund Partnership and Shanghai Fuxing Chuangfu Investment Management Co., reduced their holdings in Suobao Protein by a total of 298,000 shares [1] - The total number of shares held by Jinan Fuxing and Ningbo Fuxing decreased from 26.9461 million shares to 26.6481 million shares [1] - The percentage of total shares held by these shareholders fell from 14.08% to 13.92%, crossing a 1% threshold [1]

Core Viewpoint - The company, Suzhou Sobo Protein Technology Co., Ltd. (603231.SH), announced a share reduction by major shareholders, which has resulted in a decrease in their ownership percentage [1] Group 1: Shareholder Actions - The shareholders, Jinan Caijin Fuxing Weishi Equity Investment Fund Partnership (Limited Partnership) and Shanghai Fuxing Chuangfu Investment Management Co., Ltd., notified the company about their share reduction [1] - Between December 4 and December 5, 2025, the shareholders collectively reduced their holdings by 298,000 shares through centralized bidding transactions [1] - The total number of shares held by the shareholders decreased from 26.9461 million shares to 26.6481 million shares, reducing their ownership from 14.08% to 13.92% of the company's total share capital, crossing the 1% threshold [1]

Group 1 - The company, Suobao Protein (603231), reported that as of November 20, 2025, the number of shareholders will be 15,882 [1]

融资融券数据显示，该股最新（11月20日）两融余额为1.26亿元，其中，融资余额为1.26亿元，本期筹 码集中以来融资余额合计增加1869.45万元，增幅为17.49%。 公司发布的三季报数据显示，前三季公司共实现营业收入12.40亿元，同比增长7.37%，实现净利润1.47 亿元，同比增长60.00%，基本每股收益为0.7700元，加权平均净资产收益率7.66%。 索宝蛋白11月21日披露，截至11月20日公司股东户数为15882户，较上期（11月10日）减少1254户，环 比降幅为7.32%。这已是该公司股东户数连续第2期下降。 证券时报·数据宝统计，截至发稿，索宝蛋白收盘价为19.20元，下跌3.71%，本期筹码集中以来股价累 计下跌6.66%。具体到各交易日，2次上涨，7次下跌。 机构评级来看，近一个月该股获1家机构买入评级。预计目标价最高的是国泰海通，11月2日国泰海通发 布的研报给予公司目标价26.50元。（数据宝） （文章来源：证券时报网） ...

Core Viewpoint - The stock price of Suobao Protein has been declining for five consecutive days, with a total drop of 8.35% during this period, currently trading at 19.98 CNY per share [1] Company Overview - Suobao Protein Technology Co., Ltd. is located in Ningbo Free Trade Zone, Zhejiang Province, established on October 17, 2003, and listed on December 15, 2023. The company specializes in the research, production, and sales of soybean protein products [1] - The revenue composition of Suobao Protein includes: 32.42% from soybean isolate protein, 20.79% from non-GMO soybean oil, 19.98% from soybean concentrate protein, 17.36% from textured protein, 9.03% from other products, and 0.43% from supplementary products [1] Fund Holdings - Guolian Fund has one fund heavily invested in Suobao Protein. The Guolian Jingsheng One-Year Holding Mixed A Fund (011353) held 22,000 shares in the third quarter, accounting for 0.26% of the fund's net value, ranking as the tenth largest holding. The estimated floating loss today is approximately 7,700 CNY, with a total floating loss of 40,000 CNY during the five-day decline [2] - The Guolian Jingsheng One-Year Holding Mixed A Fund was established on May 14, 2021, with a current size of 144 million CNY. Year-to-date returns are 3.13%, ranking 7,225 out of 8,136 in its category; the one-year return is 5.23%, ranking 6,756 out of 8,055; and the return since inception is 9.07% [2] Fund Manager Information - The fund managers of Guolian Jingsheng One-Year Holding Mixed A Fund are Chen Xinyu, Huo Shunchao, and Ye Tianyang. Chen Xinyu has a tenure of 6 years and 114 days, managing assets totaling 1.211 billion CNY, with the best return of 68.57% and the worst return of -19.21% during his tenure [3] - Huo Shunchao has a tenure of 2 years and 226 days, managing assets of 16.251 billion CNY, with the best return of 30.93% and the worst return of 0.48% [3] - Ye Tianyang has a tenure of 226 days, managing assets of 2.196 billion CNY, with the best return of 2.97% and the worst return of 0.05% [3]